Increasing Potential Access to Opioid Agonist Treatment in U.S. Treatment Shortage Areas

Opioid use disorders are a significant public health problem, affecting over 2 million individuals in the US. Although opioid agonist treatment, predominantly offered in licensed methadone clinics, is both effective and cost-effective, many individuals do not receive it. Buprenorphine, approved in 2...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Health Aff (Millwood)
Asıl Yazarlar: Dick, Andrew W., Pacula, Rosalie Liccardo, Gordon, Adam J., Sorbero, Mark, Burns, Rachel M., Leslie, Douglas L., Stein, Bradley D.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2015
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4743254/
https://ncbi.nlm.nih.gov/pubmed/26056209
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1377/hlthaff.2014.1205
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller